TY  - JOUR
AU  - Ramanathan, Rajesh
AU  - Geller, David A.
PY  - 2018
TI  - Minimally invasive liver resection—more evidence of oncologic advantage
JF  - Annals of Laparoscopic and Endoscopic Surgery; Vol 3 (May 2018): Annals of Laparoscopic and Endoscopic Surgery
Y2  - 2018
KW  - 
N2  - Liver resection for colorectal cancer liver metastases (CRCLM) improves survival in patients with metachronous and synchronous metastases, and adjuvant systemic chemotherapy (AC) is often utilized (1,2). Furthermore, the timing of AC seems to be important, with studies reporting a survival benefit to initiation within 8 weeks of resection (3,4).
UR  - https://ales.amegroups.org/article/view/4505